THE CHINWAGY BUZZ · FIRST VERIFIED WORD

Astellas and Vir Biotechnology advance a strategic prostate-cancer collaboration

WHAT CHINWAGY KNOWS

The collaboration
is confirmed.

Astellas describes its partnership with Vir Biotechnology to advance VIR-5500, a PSMA-targeting dual-masked T-cell engager, through clinical development for prostate cancer.

Current status
Official collaboration
Known availability
The official source confirms the collaboration; timing details remain under review.
Place
International, Global
Source checked
September 17, 2026

SHARE OR FOLLOW THE BUZZ

Keep it moving.

Share the permanent Chinwagy profile, download a branded social card or save the story so its next update stays within reach.

FOLLOW THE STORY

More details will move this intelligence into the right Chinwagy destination.